Allotment of 550000 equity shares pursuant to the conversion of warrants issued on preferential basis, and after receipt of 75% of the exercise price from warrant holders.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions' board approved the allotment of 5,50,000 equity shares of Rs 10 each on conversion of warrants that were originally issued on a preferential basis on 13 November 2024. The company received the remaining 75% of the exercise price at Rs 45.375 per warrant (total exercise price Rs 60.50 per warrant), bringing in about Rs 2.50 crore. Two allottees took these shares: promoter Brahma Gurbani got 5,00,000 shares, raising his stake from 4.12% to 6.28%, and public shareholder Vishal Ratan Gurbani got 50,000 shares, taking his holding from 0.03% to 0.26%. As a result, the company's paid-up share capital rose from Rs 21.01 crore to Rs 21.56 crore (2.156 crore shares). Another 2,90,000 warrants remain pending conversion and must be exercised by 13 May 2026.
This is a routine completion of a previously announced preferential warrant issue — the money was largely committed earlier, so the immediate cash flow impact is limited to the Rs 2.50 crore just received. Existing shareholders face modest dilution, and the promoter's higher stake is mildly positive for confidence. Watch for further dilution if the remaining 2.9 lakh warrants are converted by May 2026.